Sign In
Buy NMRD
$0.0002
+0 (+0%)
At Close: Jun 03, 2026
Nemaura Medical (NMRD) Stock: 140.69% Increase This Past Month Explanation
09:27pm, Friday, 21'st May 2021
The stock price of Nemaura Medical Inc (NASDAQ: NMRD) increased by 140.69% this past month. This is why it happened.
Former Penny Stocks To Watch Making Their Mark In 2021
10:57am, Wednesday, 12'th May 2021
These penny stocks hit it out of the park in 2021 & continue to climb in May. The post Former Penny Stocks To Watch Making Their Mark In 2021 appeared first on Penny Stocks to Buy, Picks, News and Inf
Nemaura Medical Stages Epic Reversal
12:28pm, Thursday, 06'th May 2021
Shares of Nemaura Medical Inc. (NASDAQ:NMRD) may be about to drop even more than they have so far today. On Wednesday, the bulls were firmly in control.
NMRD Stock: 12.57% Increase (From $11.06 To $12.58) Pre-Market Explanation
08:52am, Thursday, 06'th May 2021
The stock price of Nemaura Medical Inc (NASDAQ: NMRD) increased 12.57% (from $11.06 to $12.58) pre-market. This is why it happened.
Why Nemaura Medical's Stock Surged 135% Today
04:11pm, Wednesday, 05'th May 2021
Nemaura Medical Inc. (NASDAQ: NMRD) shares are trading higher after the company receipt of a purchase order for 5,000 sugarBEAT transmitters and 200,000 sugarBEAT sensors from its U.K. licensee, DB Et
NMRD Stock: From $4.70 To $8.20 (74.46% Increase) Intraday Explanation
12:24pm, Wednesday, 05'th May 2021
The stock price of Nemaura Medical Inc (NASDAQ: NMRD) increased from $4.70 to a day high of $8.20 during intraday trading. This is why it happened.
Nemaura Medical Issues Letter to Shareholders Following April 28 Shareholder Update Call
08:04am, Thursday, 29'th Apr 2021
Loughborough, England, April 29, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializ
Nemaura Medical to Conduct Shareholder Update Call April 28, 2021, 4:30PM ET
08:10am, Wednesday, 21'st Apr 2021
Loughborough, England, April 21, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializ
Nemaura Medical Appoints Samantha Sanders as Global Head of Digital Programs
08:07am, Thursday, 15'th Apr 2021
Loughborough, England, April 15, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializ
Nemaura Medical Retains Paul Kennedy as Advisor for International Growth Opportunities and Member of the Executive Advisory Board
08:10am, Thursday, 25'th Mar 2021
Loughborough, England, March 25, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercia
Nemaura Medical Announces Submission to German Authorities for Reimbursement of its Glucose Monitoring Device
08:00am, Thursday, 11'th Mar 2021
Loughborough, England, March 11, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializ
Nemaura Medical Appoints Industry Veteran Alistair Longmuir as Advisor on Global Product Manufacture Strategy
08:00am, Thursday, 04'th Mar 2021
Loughborough, England, March 04, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializ
Nemaura Medical sees its 3Q cash balance swell to nearly $15M
11:44am, Tuesday, 16'th Feb 2021
Nemaura Medical Inc (NASDAQ:NMRD) has reported that it ended its third quarter with $14,959,785 in cash on the books as of December 31, 2020, up from $1,067,663 at the same stage a year earlier. Th
Nemaura Medical Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Corporate Update
08:30am, Tuesday, 16'th Feb 2021
Loughborough, England, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin
Nemaura Medical says it has obtained a $20 million non-dilutive, non-convertible loan
10:51am, Thursday, 11'th Feb 2021
Nemaura Medical Inc (NASDAQ:NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching progra
